Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Cardiac and microcirculatory effects of different doses of prostaglandin E1 in man.

Wilkens JH, Wilkens H, Elger B, Cassidy F, Caspary L, Creutzig A, Frölich JC.

Eur J Clin Pharmacol. 1987;33(2):133-7.

PMID:
3691606
2.
5.

Prostaglandin E1 increases myocardial contractility in the conscious dog.

Roux S, Latour JG, Théroux P, Clozel JP, Bourassa MG.

Can J Physiol Pharmacol. 1984 Dec;62(12):1505-10.

PMID:
6543330
6.

Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.

Bund M, Henzler D, Walz R, Rossaint R, Piepenbrock S.

Thorac Cardiovasc Surg. 2006 Aug;54(5):341-7.

PMID:
16902884
7.
8.

Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.

Wimmer A, Stanek B, Kubecova L, Vitovec J, Spinar J, Yilmaz N, Kos T, Hartter E, Frey B, Pacher R.

Jpn Heart J. 1999 May;40(3):321-34.

9.

Effects of phenylephrine and prostaglandin E1 on ventriculo-arterial matching during halothane anaesthesia.

Hoka S, Kawasaki T, Okamoto H, Okuyama T, Takahashi S.

Br J Anaesth. 1995 Apr;74(4):438-42.

PMID:
7734265
11.

Prostaglandin E1 attenuates the hypertensive response to tracheal extubation.

Nishina K, Mikawa K, Shiga M, Maekawa N, Obara H.

Can J Anaesth. 1996 Jul;43(7):678-83.

PMID:
8807172
12.

Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.

Miyamori I, Morise T, Yasuhara S, Takeda Y, Koshida H, Takeda R.

Br J Clin Pharmacol. 1985 Dec;20(6):681-3.

13.
14.

About mechanisms of prostaglandin E1 induced deterioration of pulmonary gas exchange in COPD patients.

Dujić Z, Eterović D, Tocilj J, Kusić Z, Capkun V.

Clin Physiol. 1993 Sep;13(5):497-506.

PMID:
8222534
15.

Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.

Zhao L, Lu J, Wang C, Zhao W, Qing E, Ma J.

J Cardiothorac Vasc Anesth. 2013 Dec;27(6):1208-11. doi: 10.1053/j.jvca.2013.07.001. Epub 2013 Sep 30.

PMID:
24090805
16.

Therapeutic efficacy of intravenously applied prostaglandin E1.

Scheffler P, de la Hamette D, Leipnitz G.

Vasa Suppl. 1989;28:19-25.

PMID:
2609240
17.

Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation.

Saeki S, Yamamura K, Matsushita M, Nishikimi N, Sakurai T, Nimura Y.

Int J Clin Pharmacol Ther. 1998 Oct;36(10):525-9.

PMID:
9799055
18.
19.

Cerebral oxygenation during prostaglandin E1 induced hypotension.

Kadoi Y, Saito S, Kunimoto F, Morita T, Goto F, Kawahara F, Fujita N.

Can J Anaesth. 1998 Sep;45(9):860-4.

PMID:
9818109
20.

The differential effects of prostaglandin E1 and nitroglycerin on regional cerebral oxygenation in anesthetized patients.

Kadoi Y, Saito S, Morita T, Imai T, Kawahara H, Fujita N, Goto F.

Anesth Analg. 1997 Nov;85(5):1054-9.

PMID:
9356099

Supplemental Content

Support Center